MyoPax

MyoPax is a biotechnology startup focused on developing innovative regenerative therapies for debilitating muscle diseases. It was spun off from Charité Universitätsmedizin Berlin and the Max Delbrück Center of the Helmholtz Association. MyoPax has over 30 years of relevant experience in the research and development of human skeletal muscle, backed by strong scientific expertise, cutting-edge technology, and outstanding clinical proficiency.